A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1
NCT00033124 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-01-11
Summary
The purpose of this study is to examine behavioral treatment for methamphetamine dependence.
Conditions
- Substance-Related Disorders
Interventions
- BEHAVIORAL
-
Behavior Therapy
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Richard Rawson, Ph.D. · National Institute on Drug Abuse (NIDA)
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-07-31
- Completion
- 2002-06-30
Countries
- United States
Study Locations
More Related Trials
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
NCT01011829 ·Status: COMPLETED ·Phase: PHASE2
-
A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence
NCT01577797 ·Status: COMPLETED ·Phase: PHASE1
-
Tyrosine for Methamphetamine Dependence - 1
NCT00000322 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
NCT00653263 ·Status: COMPLETED
-
Ondansetron for the Treatment of Methamphetamine Dependence - 1
NCT00040053 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Medical Treatment for Methamphetamine Addiction
NCT00833443 ·Status: COMPLETED ·Phase: PHASE2
-
Buspirone as a Candidate Medication for Methamphetamine Abuse
NCT01843205 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Correlates of Substance Abuse - 11
NCT00000346 ·Status: UNKNOWN ·Phase: PHASE4
-
Methamphetamine Abuse Treatment in Patients With AIDS - 1
NCT00000321 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
NCT00687713 ·Status: COMPLETED ·Phase: PHASE2
-
RTI-336 as a Treatment for Methamphetamine Dependence
NCT01601717 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
NCT00630682 ·Status: COMPLETED ·Phase: PHASE2
-
Psychostimulant Abuse - Novel Treatment Approaches - 1
NCT00000325 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
NCT00136734 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
NCT00292110 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction
NCT00571922 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000241 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
NCT00040040 ·Status: UNKNOWN ·Phase: PHASE1
-
NAC as a Potential Treatment for Methamphetamine Dependence
NCT01063205 ·Status: COMPLETED ·Phase: PHASE1
-
Rivastigmine as a Treatment for Methamphetamine Dependence
NCT01073319 ·Status: COMPLETED ·Phase: PHASE1
-
Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
NCT00809835 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Extended Treatments for Drug Dependence
NCT00685659 ·Status: COMPLETED ·Phase: NA